Globe Life GL Health — Non-deferred acquisition costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globe Life in its filing.
Tagged under the XBRL concept gl:NonDeferredAcquisitionCosts.
The official record: Globe Life’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globe Life's health — non-deferred acquisition costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globe Life's health — non-deferred acquisition costs?
- Globe Life (GL) reported health — non-deferred acquisition costs of $16.3M in Q1 2026.
- How has Globe Life's health — non-deferred acquisition costs changed year-over-year?
- Globe Life's health — non-deferred acquisition costs increased by 12.2% year-over-year, from $14.53M to $16.3M.
- What is the long-term trend for Globe Life's health — non-deferred acquisition costs?
- Over 3 years (2022 to 2025), Globe Life's health — non-deferred acquisition costs has grown at a 15.2% compound annual growth rate (CAGR), from $36.71M to $56.1M.
- What does health — non-deferred acquisition costs mean?
- Expenses incurred to acquire new health insurance business that do not qualify for deferral under accounting standards and are therefore expensed immediately. These include certain administrative and underwriting costs associated with the initial policy issuance.